In patients with Parkinson’s disease (PD), the localization of AQP4 in the end-feet of astrocytes is reduced (AQP4 depolarization), manifested as metabolic disorders in cerebrospinal fluid reflux and neurotransmitter clearance related to the impaired glymphatic system [113]. This evidence concerns the gene AQP4 and metabolic disease.